Replies to post #6118 on Calypte Biomedical Corp (fka CBMC)

[bloodhound99]

Axiom

Your logic makes perfect sense, and is realistic in playing the pop on the stock.

I have always said the test SHOULD be approved by China. My concern was always would they be able to sell any.

However I agree that approval by SFDA should be forthcoming and that it should cause a PPS increase in exactly the manner you said.

Only problem is that YOU and I are thinking logically and that hasn't always proved to be the case with either China or Calypte management.

[bloodhound99]

Another consideration will be how many shares are available at time of SFDA approval. If there are a few as it sits now, the price could rise up to $ ,25 or maybe $ .35 on approval news.

However if the new investors get their 100,000,000 plus $ .052 shares registered for sale before the SFDA approval, then I think the flood of shares might stiffle any real run, especially if the new investors could triple their 5 million dollar investment at about $ .15 and not have to worry about whether the tests would sell at all.

Good Luck Axiom, and here's hoping the SFDA approval comes out before the new investors stock becomes eligible for sale.